{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T01:52:38Z","timestamp":1761789158799},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejoncologynursing.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Oncology Nursing"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.ejon.2014.11.003","type":"journal-article","created":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T23:45:45Z","timestamp":1418773545000},"page":"260-267","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Symptoms of hormonal therapy and social support: Is there a connection? Comparison of symptom severity, symptom interference and social support among breast cancer patients receiving and not receiving adjuvant hormonal treatment"],"prefix":"10.1016","volume":"19","author":[{"given":"Lea","family":"Ochayon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"Tunin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aviva","family":"Yoselis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilana","family":"Kadmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejon.2014.11.003_bib1","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1200\/JCO.2005.03.475","article-title":"Persistence of restrictions in quality of life from the first to the third year after diagnosis in women in breast cancer","volume":"23","author":"Arndt","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.ejon.2014.11.003_bib2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/pon.1033","article-title":"Psychometric properties of a tool for measuring hormone-related symptoms in breast cancer survivors","volume":"15","author":"Alfano","year":"2006","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.ejon.2014.11.003_bib3","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/cncr.22274","article-title":"A\u00a0population-based study of the impact of specific symptoms on quality of life in women with breast cancer 1 year after diagnosis","volume":"107","author":"Arndt","year":"2006","journal-title":"Cancer"},{"author":"ATAC Trialists' Group","key":"10.1016\/j.ejon.2014.11.003_bib4"},{"key":"10.1016\/j.ejon.2014.11.003_bib5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1470-2045(06)70767-7","article-title":"Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial","volume":"7","author":"ATAC Trialists' Group","year":"2006","journal-title":"Lancet Oncology"},{"key":"10.1016\/j.ejon.2014.11.003_bib6","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1200\/JCO.2005.05.130","article-title":"Quality of life among younger women with breast cancer","volume":"23","author":"Avis","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.ejon.2014.11.003_bib7","doi-asserted-by":"crossref","first-page":"3494S","DOI":"10.1093\/jn\/132.11.3494S","article-title":"Cancer survivorship research: challenge and opportunity","volume":"132","author":"Aziz","year":"2002","journal-title":"Journal of Nutrition"},{"key":"10.1016\/j.ejon.2014.11.003_bib8","first-page":"567","article-title":"Depression burden, self-help interventions, and side effect experience in women receiving treatment for breast cancer","volume":"28","author":"Badger","year":"2001","journal-title":"Oncology Nursing Forum"},{"key":"10.1016\/j.ejon.2014.11.003_bib9","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/cncr.22485","article-title":"Early discontinuation of tamoxifen: a lesson for oncologists","volume":"109","author":"Barron","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejon.2014.11.003_bib10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00002820-200505000-00011","article-title":"Symptom clusters in breast cancer across 3 phases of the disease","volume":"28","author":"Bender","year":"2005","journal-title":"Cancer Nursing"},{"key":"10.1016\/j.ejon.2014.11.003_bib11","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1056\/NEJMoa052258","article-title":"A\u00a0comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer","volume":"353","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ejon.2014.11.003_bib12","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0167-6296(02)00059-0","article-title":"Breast cancer survival, work, and earnings","volume":"21","author":"Bradley","year":"2002","journal-title":"Journal of Health Economics"},{"key":"10.1016\/j.ejon.2014.11.003_bib13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0960-0760(03)00350-9","article-title":"Arimidex\u00ae (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer\u2014efficacy overview","volume":"86","author":"Buzdar","year":"2003","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"7","key":"10.1016\/j.ejon.2014.11.003_bib14","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V","article-title":"Assessing symptom distress in cancer patients: the M. D. Anderson Symptom Inventory","volume":"89","author":"Cleeland","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ejon.2014.11.003_bib15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00520-005-0003-8","article-title":"Issues and concerns of young Australian women with breast cancer","volume":"14","author":"Connell","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejon.2014.11.003_bib16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/pon.3049","article-title":"Distinct work-related, clinical and psychological factors predict return to work following treatment in four different cancer types","volume":"22","author":"Cooper","year":"2013","journal-title":"Psycho-Oncology"},{"issue":"9","key":"10.1016\/j.ejon.2014.11.003_bib17","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1200\/JCO.1999.17.9.2659","article-title":"Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"17","author":"Day","year":"1999","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.ejon.2014.11.003_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00006199-200507000-00004","article-title":"An analytic strategy for modeling multiple-item responses","volume":"54","author":"Doorenbos","year":"2005","journal-title":"Nursing Research"},{"key":"10.1016\/j.ejon.2014.11.003_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/pon.1519","article-title":"Determinants of physical activity among women treated for breast cancer in a 5-year longitudinal follow up investigation","volume":"18","author":"Emery","year":"2009","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.ejon.2014.11.003_bib20","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1200\/JCO.2005.03.3654","article-title":"Quality of life in the Intergroup Exemestane Study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer","volume":"24","author":"Fallowfield","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.ejon.2014.11.003_bib21","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1200\/JCO.2005.01.6550","article-title":"Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study","volume":"23","author":"Fan","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1016\/j.ejon.2014.11.003_bib22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/jnci\/djq542","article-title":"Assessing the quality and value of quality-of-life measurement in breast cancer clinical trials","volume":"103","author":"Ganz","year":"2011","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"10.1016\/j.ejon.2014.11.003_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jnci\/94.1.39","article-title":"Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study","volume":"94","author":"Ganz","year":"2002","journal-title":"Journal of the National Cancer Institute"},{"issue":"21","key":"10.1016\/j.ejon.2014.11.003_bib24","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1200\/JCO.2003.08.097","article-title":"Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis","volume":"21","author":"Ganz","year":"2003","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.ejon.2014.11.003_bib25","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/jnci\/djh060","article-title":"Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial","volume":"96","author":"Ganz","year":"2004","journal-title":"Journal of the National Cancer Institute"},{"issue":"9","key":"10.1016\/j.ejon.2014.11.003_bib26","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1200\/JCO.2010.28.8043","article-title":"Physical and psychosocial recovery in the year after primary treatment of breast cancer","volume":"29","author":"Ganz","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.ejon.2014.11.003_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1037\/1091-7527.23.2.161","article-title":"Breast cancer: how do Israeli women cope? A cross-sectional sample","volume":"23","author":"Gilbar","year":"2005","journal-title":"Families, Systems, Health"},{"issue":"5","key":"10.1016\/j.ejon.2014.11.003_bib28","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/annonc\/mdl030","article-title":"Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment","volume":"17","author":"Glaus","year":"2006","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.ejon.2014.11.003_bib29","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for Breast-Cancer prevention in postmenopausal women","volume":"364","author":"Goss","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ejon.2014.11.003_bib30","doi-asserted-by":"crossref","unstructured":"Hallquist Viale, P., 2005. Aromatase inhibitor agents in breast Cancer: evolving practices in hormonal therapy treatment. Oncology Nursing Forum, 32(2), 343\u2013353.","DOI":"10.1188\/05.ONF.343-353"},{"issue":"6","key":"10.1016\/j.ejon.2014.11.003_bib31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1188\/04.CJON.629-637","article-title":"Advances in endocrine therapy for breast cancer: considering efficacy, safety, and quality of life","volume":"8","author":"Harwood","year":"2004","journal-title":"Clinical Journal of Oncology Nursing"},{"issue":"2","key":"10.1016\/j.ejon.2014.11.003_bib32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10549-010-1132-4","article-title":"Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer","volume":"126","author":"Hershman","year":"2011","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1016\/j.ejon.2014.11.003_bib33","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/annonc\/mdn025","article-title":"Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations","volume":"19","author":"Hery","year":"2008","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.ejon.2014.11.003_bib34","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1200\/JCO.2011.41.4375","article-title":"Change in working time in a population-based cohort of patients with breast cancer","volume":"30","author":"Hoyer","year":"2012","journal-title":"Journal of Clinical Oncology"},{"issue":"13","key":"10.1016\/j.ejon.2014.11.003_bib35","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.ejca.2012.03.004","article-title":"Early discontinuation of tamoxifen intake in younger women with breast cancer: is it time to rethink the way it is prescribed?","volume":"48","author":"Huiart","year":"2012","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.ejon.2014.11.003_bib36","unstructured":"Israel Cancer Association. Breast Cancer, n.d. Web. 31 Mar. 2014."},{"author":"Israel National Cancer Registry","key":"10.1016\/j.ejon.2014.11.003_bib37"},{"issue":"9","key":"10.1016\/j.ejon.2014.11.003_bib38","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1089\/jwh.2006.0255","article-title":"Symptom experience and quality of life of women following breast Cancer treatment","volume":"16","author":"Janz","year":"2007","journal-title":"Journal of Women's Health"},{"key":"10.1016\/j.ejon.2014.11.003_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.gco.0000192996.20040.24","article-title":"Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients","volume":"18","author":"Kayl","year":"2006","journal-title":"Current Opinion in Obstetrics & Gynecology"},{"key":"10.1016\/j.ejon.2014.11.003_bib40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1188\/06.ONF.327-335","article-title":"Patterns of symptom distress in older women after surgical treatment of breast cancer","volume":"33","author":"Kenefick","year":"2006","journal-title":"Oncology Nursing Forum"},{"key":"10.1016\/j.ejon.2014.11.003_bib41","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jpainsymman.2007.11.011","article-title":"Treatment-related symptom clusters in breast cancer: a secondary analysis","volume":"36","author":"Kim","year":"2008","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1016\/j.ejon.2014.11.003_bib42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1547-5069.2009.01267.x","article-title":"Predictors of the intensity of symptoms in a cluster in patients with breast cancer","volume":"41","author":"Kim","year":"2009","journal-title":"Journal of Nursing Scholarship"},{"key":"10.1016\/j.ejon.2014.11.003_bib43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00002820-200106000-00006","article-title":"The menopausal symptom experience in young mid-life women with breast cancer","volume":"24","author":"Knobf","year":"2001","journal-title":"Cancer Nursing"},{"issue":"23","key":"10.1016\/j.ejon.2014.11.003_bib44","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1001\/jama.295.23.joc60075","article-title":"Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Land","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ejon.2014.11.003_bib45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0960-9776(96)90021-1","article-title":"Impact of side-effects associated with endocrine treatment for advanced breast cancer: clinicians' and patients' perceptions","volume":"5","author":"Leonard","year":"1996","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.ejon.2014.11.003_bib46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/1049732304270766","article-title":"Quality-of-Life concerns of African American Breast Cancer survivors within Rural North Carolina: Blending the Techniques of Photovoice and Grounded Theory","volume":"15","author":"L\u00f3pez","year":"2005","journal-title":"Qualitative Health Research"},{"issue":"49","key":"10.1016\/j.ejon.2014.11.003_bib47","first-page":"126","article-title":"Social support and survival among women with breast cancer","volume":"193","author":"Maunsell","year":"1995","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejon.2014.11.003_bib48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10549-012-2114-5","article-title":"Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review","volume":"134","author":"Murphy","year":"2012","journal-title":"Breast Cancer Research and Treatment"},{"issue":"5","key":"10.1016\/j.ejon.2014.11.003_bib49","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1188\/11.ONF.523-531","article-title":"Coping resources and self-rated health among Latina breast cancer survivors","volume":"38","author":"N\u00e1poles","year":"2011","journal-title":"Oncology Nursing Forum"},{"issue":"1","key":"10.1016\/j.ejon.2014.11.003_bib50","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10549-012-2066-9","article-title":"Non-initiation of adjuvant hormonal therapy in women with hormone receptor positive breast cancer: the Breast Cancer Quality of Care Study (B-QUAL)","volume":"134","author":"Neuget","year":"2012","journal-title":"Breast Cancer Research Treatment."},{"issue":"1","key":"10.1016\/j.ejon.2014.11.003_bib51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/(SICI)1099-1611(199801\/02)7:1<37::AID-PON314>3.0.CO;2-#","article-title":"Couple's adjustment to breast cancer and benign breast disease: a longitudinal analysis","volume":"7","author":"Northouse","year":"1998","journal-title":"Psycho-Oncology"},{"issue":"5","key":"10.1016\/j.ejon.2014.11.003_bib52","doi-asserted-by":"crossref","first-page":"E349","DOI":"10.1188\/10.ONF.E349-E358","article-title":"Relationship between severity of symptoms and quality of life in patients with breast cancer receiving adjuvant hormonal therapy","volume":"37","author":"Ochayon","year":"2010","journal-title":"Oncology Nursing Forum"},{"key":"10.1016\/j.ejon.2014.11.003_bib53","series-title":"Health at a Glance 2011: OECD Indicators","article-title":"Mortality from cancer","author":"OECD","year":"2011"},{"key":"10.1016\/j.ejon.2014.11.003_bib54","first-page":"74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"6","key":"10.1016\/j.ejon.2014.11.003_bib55","doi-asserted-by":"crossref","first-page":"E411","DOI":"10.1188\/10.ONF.E411-E418","article-title":"The relationship between symptom severity and symptom interference, education, age, marital status and type of chemotherapy treatment in Israeli women with early stage (I and II) breast cancer receiving adjuvant chemotherapy","volume":"37","author":"Prigozin","year":"2010","journal-title":"Oncology Nursing Forum"},{"year":"2009","series-title":"The Relationship between Symptom Severity, Symptom Interference and Social Support among Men with Prostate Cancer Receiving Radiotherapy Treatment","author":"Rabinowitz","key":"10.1016\/j.ejon.2014.11.003_bib56"},{"issue":"1","key":"10.1016\/j.ejon.2014.11.003_bib57","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1188\/10.ONF.E28-E33","article-title":"Confronting the unexpected: temporal, situational and attributive dimensions of distressing symptom experience for the breast cancer survivor","volume":"37","author":"Rosedale","year":"2010","journal-title":"Oncology Nursing Forum"},{"issue":"4","key":"10.1016\/j.ejon.2014.11.003_bib58","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1188\/09.ONF.463-470","article-title":"Older breast cancer survivors' symptom beliefs","volume":"36","author":"Royer","year":"2009","journal-title":"Oncology Nursing Forum"},{"issue":"5","key":"10.1016\/j.ejon.2014.11.003_bib59","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/NCC.0b013e31819e23b7","article-title":"Quality of life of breast cancer survivors","volume":"32","author":"Sammarco","year":"2009","journal-title":"Cancer Nursing"},{"issue":"9","key":"10.1016\/j.ejon.2014.11.003_bib60","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/pon.1120","article-title":"The course of severe fatigue in disease-free breast cancer patients: a longitudinal study","volume":"16","author":"Servaes","year":"2007","journal-title":"Psycho-Oncology"},{"issue":"1","key":"10.1016\/j.ejon.2014.11.003_bib61","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejon.2006.02.005","article-title":"Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer","volume":"11","author":"Shilling","year":"2007","journal-title":"European Journal of Oncology Nursing"},{"issue":"4","key":"10.1016\/j.ejon.2014.11.003_bib62","doi-asserted-by":"crossref","first-page":"E205","DOI":"10.1188\/09.ONF.E205-E214","article-title":"The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a Multicenter study","volume":"36","author":"So","year":"2009","journal-title":"Oncology Nursing Forum"},{"issue":"6","key":"10.1016\/j.ejon.2014.11.003_bib63","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/jnci\/dji069","article-title":"The BCPT Scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer","volume":"97","author":"Stanton","year":"2005","journal-title":"Journal of the National Cancer Institute"},{"issue":"22","key":"10.1016\/j.ejon.2014.11.003_bib64","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1200\/JCO.2003.01.119","article-title":"Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer","volume":"21","author":"Tchen","year":"2003","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"10.1016\/j.ejon.2014.11.003_bib65","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1037\/a0031894","article-title":"Perceived social support change in patients with early stage breast cancer and controls","volume":"32","author":"Thompson","year":"2013","journal-title":"Health Psychology"},{"key":"10.1016\/j.ejon.2014.11.003_bib66","first-page":"52","article-title":"Hormonal treatment of breast cancer","volume":"17","author":"Vigler","year":"2002","journal-title":"Bama"},{"key":"10.1016\/j.ejon.2014.11.003_bib67","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.breast.2007.11.001","article-title":"Effectively nursing patients receiving aromatase inhibitor therapy","volume":"17","author":"Wengstrom","year":"2008","journal-title":"The Breast"},{"issue":"3, Pt. 2","key":"10.1016\/j.ejon.2014.11.003_bib68","doi-asserted-by":"crossref","first-page":"1056S","DOI":"10.1158\/1078-0432.CCR-05-2185","article-title":"Managing patients on endocrine therapy: focus on quality-of-life issues","volume":"12","author":"Whelan","year":"2006","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.ejon.2014.11.003_bib69","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1188\/04.CJON.87-88","article-title":"Anastrozole (Arimidex\u00ae)","volume":"8","author":"Wilkinson","year":"2004","journal-title":"Clinical Journal of Oncology Nursing"},{"key":"10.1016\/j.ejon.2014.11.003_bib70","series-title":"Cancer\u2013Principles and Practice of Oncology","first-page":"1415","article-title":"Malignant tumors of the breast","author":"Woods","year":"2005"},{"issue":"3","key":"10.1016\/j.ejon.2014.11.003_bib71","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10549-011-1660-6","article-title":"Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II)","volume":"132","author":"Zambetti","year":"2012","journal-title":"Breast Cancer Research and Treatment"},{"issue":"5","key":"10.1016\/j.ejon.2014.11.003_bib72","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1523-5394.2000.85004.x","article-title":"Cancer survivor and quality of life","volume":"8","author":"Zebrach","year":"2002","journal-title":"Cancer Practice"},{"issue":"1","key":"10.1016\/j.ejon.2014.11.003_bib73","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1207\/s15327752jpa5201_2","article-title":"The multidimensional scale of perceived social support","volume":"52","author":"Zimet","year":"1988","journal-title":"Journal of Personality Assessment"}],"container-title":["European Journal of Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388914001926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388914001926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T10:29:08Z","timestamp":1566124148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1462388914001926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1462388914001926"],"URL":"https:\/\/doi.org\/10.1016\/j.ejon.2014.11.003","relation":{},"ISSN":["1462-3889"],"issn-type":[{"type":"print","value":"1462-3889"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptoms of hormonal therapy and social support: Is there a connection? Comparison of symptom severity, symptom interference and social support among breast cancer patients receiving and not receiving adjuvant hormonal treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejon.2014.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}